These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23399042)

  • 21. Sharing in the financing of health care: government, insurance and the patient.
    Ron A
    Health Policy; 1986; 6(1):87-101. PubMed ID: 10276318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do health-related labour costs weaken the competitiveness of the economy?
    Häussler B; Ecker T; Schneider M
    Pharmacoeconomics; 2006 Dec; 24 Suppl 2():59-68. PubMed ID: 23389489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of federalism on the healthcare system in terms of efficiency, equity, and cost containment: the case of Switzerland.
    Crivelli L; Salari P
    Dev Health Econ Public Policy; 2014; 12():155-78. PubMed ID: 24864386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International genetic evaluation of dairy sires using a multiple-trait model with individual animal performance records.
    Weigel KA; Rekaya R; Zwald NR; Fikse WF
    J Dairy Sci; 2001 Dec; 84(12):2789-95. PubMed ID: 11814036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Competitive Health Markets and Risk Equalisation in Australia: Lessons Learnt from Other Countries.
    Fouda A; Fiorentini G; Paolucci F
    Appl Health Econ Health Policy; 2017 Dec; 15(6):745-754. PubMed ID: 28439816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health system reforms in industrialized democracies: an emerging paradigm.
    Chernichovsky D
    Milbank Q; 1995; 73(3):339-72. PubMed ID: 7659044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Swiss and Dutch "consumer-driven health care": ideal model or reality?
    Okma KG; Crivelli L
    Health Policy; 2013 Feb; 109(2):105-12. PubMed ID: 23122805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scope and Incentives for Risk Selection in Health Insurance Markets With Regulated Competition: A Conceptual Framework and International Comparison.
    van Kleef RC; Reuser M; McGuire TG; Armstrong J; Beck K; Brammli-Greenberg S; Ellis RP; Paolucci F; Schokkaert E; Wasem J
    Med Care Res Rev; 2024 Jun; 81(3):175-194. PubMed ID: 38284550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managed competition in the Netherlands-a qualitative study.
    Heinemann S; Leiber S; Gress S
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk sharing as a supplement to imperfect capitation: a tradeoff between selection and efficiency.
    van Barneveld EM; Lamers LM; van Vliet RC; van de Ven WP
    J Health Econ; 2001 Mar; 20(2):147-68. PubMed ID: 11252368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Managed competition" for Ireland? The single versus multiple payer debate.
    Mikkers M; Ryan P
    BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When do developing countries adopt managed care policies and technologies? Part I: Policies, experience, and a framework of preconditions.
    Peabody JW; Luck J
    Am J Manag Care; 2002 Nov; 8(11):997-1007. PubMed ID: 12437314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of hospital utilization: the situation in Israel and selected countries.
    Benbassat J; Haklai Z; Glick S; Friedman N
    Isr Med Assoc J; 2000 Nov; 2(11):833-7. PubMed ID: 11344753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing choices in health care: implications for equity, efficiency and cost.
    Bevan G; Helderman JK; Wilsford D
    Health Econ Policy Law; 2010 Jul; 5(3):251-67. PubMed ID: 20478104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of health insurance market reforms on market competition.
    Hall MA
    Am J Manag Care; 2000 Jan; 6(1):57-67. PubMed ID: 11009747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overpaying morbidity adjusters in risk equalization models.
    van Kleef RC; van Vliet RC; van de Ven WP
    Eur J Health Econ; 2016 Sep; 17(7):885-95. PubMed ID: 26420555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The German Central Health Fund-recent developments in health care financing in Germany.
    Göpffarth D; Henke KD
    Health Policy; 2013 Mar; 109(3):246-52. PubMed ID: 23200602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Netherlands introduces some competition into the health services.
    Schrijvers AJ
    JAMA; 1991 Oct 23-30; 266(16):2215-7. PubMed ID: 1823541
    [No Abstract]   [Full Text] [Related]  

  • 39. An experiment with regulated competition and individual mandates for universal health care: the new Dutch health insurance system.
    Rosenau PV; Lako CJ
    J Health Polit Policy Law; 2008 Dec; 33(6):1031-55. PubMed ID: 19038869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk equalization, competition, and choice: a preliminary assessment of the 1993 German health reforms.
    Wysong JA; Abel T
    Soz Praventivmed; 1996; 41(4):212-23. PubMed ID: 8806157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.